These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23045419)

  • 1. Genetic defects in the cyp21a2 gene in heterozygous girls with premature adrenarche and adolescent females with hyperandrogenemia.
    Neocleous V; Shammas C; Phedonos AP; Karaoli E; Kyriakou A; Toumba M; Phylactou LA; Skordis N
    Georgian Med News; 2012 Sep; (210):40-7. PubMed ID: 23045419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic defects of the CYP21A2 gene in girls with premature adrenarche.
    Skordis N; Shammas C; Phedonos AA; Kyriakou A; Toumba M; Neocleous V; Phylactou LA
    J Endocrinol Invest; 2015 May; 38(5):535-9. PubMed ID: 25481255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
    Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
    Knochenhauer ES; Cortet-Rudelli C; Cunnigham RD; Conway-Myers BA; Dewailly D; Azziz R
    J Clin Endocrinol Metab; 1997 Feb; 82(2):479-85. PubMed ID: 9024240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation.
    Shammas C; Byrou S; Phelan MM; Toumba M; Stylianou C; Skordis N; Neocleous V; Phylactou LA
    Hormones (Athens); 2016 Apr; 15(2):235-242. PubMed ID: 27376426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations.
    Neocleous V; Shammas C; Phedonos AA; Phylactou LA; Skordis N
    Indian J Endocrinol Metab; 2014 Nov; 18(Suppl 1):S72-9. PubMed ID: 25538881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.
    Kelestimur F; Everest H; Dundar M; Tanriverdi F; White C; Witchel SF
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):205-8. PubMed ID: 19085698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
    Guarnotta V; Niceta M; Bono M; Marchese S; Fabiano C; Indelicato S; Di Gaudio F; Garofalo P; Giordano C
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105554. PubMed ID: 31805392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature pubarche in Mediterranean girls: high prevalence of heterozygous CYP21 mutation carriers.
    Paris F; Tardy V; Chalançon A; Picot MC; Morel Y; Sultan C
    Gynecol Endocrinol; 2010 May; 26(5):319-24. PubMed ID: 20059433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in hormonal levels between heterozygous
    Silva RS; Carvalho B; Pedro J; Castro-Correia C; Carvalho D; Carvalho F; Fontoura M
    Arch Endocrinol Metab; 2022 Apr; 66(2):168-175. PubMed ID: 35289513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
    Ghizzoni L; Cappa M; Vottero A; Ubertini G; Carta D; Di Iorgi N; Gasco V; Marchesi M; Raggi V; Ibba A; Napoli F; Massimi A; Maghnie M; Loche S; Porzio O
    Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Clinical Outcome of CYP21A2 Gene Mutations in Patients with Nonfunctional Adrenal Incidentalomas.
    Kiedrowicz B; Binczak-Kuleta A; Lubikowski J; Koziolek M; Andrysiak-Mamos E; Ostanek-Panka M; Ciechanowicz A; Syrenicz A
    Horm Metab Res; 2015 Aug; 47(9):662-7. PubMed ID: 25970792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia.
    Neocleous V; Ioannou YS; Bartsota M; Costi C; Skordis N; Phylactou LA
    Clin Biochem; 2009 Sep; 42(13-14):1363-7. PubMed ID: 19501079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency.
    Witchel SF; Lee PA; Suda-Hartman M; Hoffman EP
    Biochem Mol Med; 1997 Dec; 62(2):151-8. PubMed ID: 9441866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detected heterozygotes during the molecular analysis of the common CYP21A2 point mutations in Macedonian patients with congenital adrenal hyperplasia and their relatives.
    Anastasovska V; Kocova M
    Prilozi; 2010; 31(2):71-82. PubMed ID: 21258279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance.
    Khattab A; Yuen T; Al-Malki S; Yau M; Kazmi D; Sun L; Harbison M; Haider S; Zaidi M; New MI
    Ann N Y Acad Sci; 2016 Jan; 1364(1):5-10. PubMed ID: 26291314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17-Hydroxyprogesterone Response to Standard Dose Synacthen Stimulation Test in
    Polat S; Arslan YK
    J Clin Res Pediatr Endocrinol; 2022 Mar; 14(1):56-68. PubMed ID: 34743977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High carrier frequency of 21-hydroxylase deficiency in Cyprus.
    Phedonos AA; Shammas C; Skordis N; Kyriakides TC; Neocleous V; Phylactou LA
    Clin Genet; 2013 Dec; 84(6):585-8. PubMed ID: 23600966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.
    Livadas S; Dracopoulou M; Dastamani A; Sertedaki A; Maniati-Christidi M; Magiakou AM; Kanaka-Gantenbein C; Chrousos GP; Dacou-Voutetakis C
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):543-9. PubMed ID: 25041270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.